Lei Fang
Corporate Officer/Principal bij LEPU BIOPHARMA CO., LTD.
Profiel
Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd.
and also holds a current position at CtM Bio Co., Ltd.
Dr. Fang was previously the Director of Research & Development at I-MAB Biopharma Co., Ltd.
from 2016 to 2020.
Additionally, Dr. Fang was a Director at Third Venture Biopharma (Nanjing) Co., Ltd.
Dr. Fang received a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University in 2004.
Actieve functies van Lei Fang
Bedrijven | Functie | Begin |
---|---|---|
LEPU BIOPHARMA CO., LTD. | Corporate Officer/Principal | 10-12-2020 |
CtM Bio Co., Ltd. | Algemeen Directeur | - |
Eerdere bekende functies van Lei Fang
Bedrijven | Functie | Einde |
---|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Third Venture Biopharma (Nanjing) Co., Ltd. | Directeur/Bestuurslid | - |
Opleiding van Lei Fang
Chinese Academy of Sciences | Doctorate Degree |
Hebei University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LEPU BIOPHARMA CO., LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
CtM Bio Co., Ltd. | |
Third Venture Biopharma (Nanjing) Co., Ltd. |